A ROS-responsive TPZ prodrug micelle for co-delivery with doxorubicin in synergistic cancer therapy
Fields of Study & Subjects
Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
Cancer
Hypoxia
and Metabolism
Publication details
- Journal / source
- Chinese Chemical Letters
- Publisher
- Elsevier BV
- Pages
- 112466–112466
- Publication date
- 1 January 2026
- Language
- EN